ESROSITA-M 50/1000 Tablets – Dual Action Diabetes Control
Description:
ESROSITA-M 50/1000 Tablets combine Sitagliptin Phosphate Monohydrate (50 mg) and Metformin Hydrochloride Prolonged Release (1000 mg) to provide effective glycemic control in adults with Type 2 Diabetes Mellitus. This powerful dual-action formulation helps lower blood sugar by improving insulin sensitivity and enhancing incretin hormone activity, making it a reliable choice for long-term diabetes management.
Composition (per tablet):
Metformin Hydrochloride IP (Prolonged Release): 1000 mg
Sitagliptin Phosphate Monohydrate IP: Equivalent to Sitagliptin 50 mg
MRP: ₹223/-
Pack Size: 10 × 15 Tablets
Key Benefits:
Helps control high blood sugar in Type 2 Diabetes
Supports healthy weight management by reducing insulin resistance
Improves post-meal and fasting blood sugar levels
Convenient once-daily dosing with prolonged-release formulation
Reduces the risk of diabetes-related complications
Dosage: As prescribed by a healthcare professional.
Why Choose Esroford Pharma:
WHO-GMP certified manufacturing standards
Clinically researched formulations
Affordable, high-quality medicines
Wide availability and reliable supply chain
